Study shows MRgFUS improves dysmenorrhea and reduces uterine size in patients with adenomyosis, indicating its potential as a non-invasive treatment.
Motivation: The symptoms of dysmenorrhea, infertility and hypermenorrhea caused by adenomyosis seriously affect the daily life of patients. Therefore, there is an urgent need for an effective non-invasive treatment of uterine adenomyosis. Goal(s): To investigate the safety and efficacy of Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgFUS) treatment on adenomyosis. Approach: MRgFUS was performed on 62 adenomyosis patients to observe the adverse reactions during treatment, the changes of uterine size and improvement of dysmenorrhea. Results: All 62 patients successfully underwent MRgFUS treatment without severe adverse reactions(average ablation rate 69.12%±17.64%). Post-treatment uterine volume and dysmenorrhea scores showed statistically significant improvements compared to pre-treatment (p<0.05). Impact: MRgFUS is safe and effective in the treatment of uterine adenomyosis, and is a new non-invasive treatment approach.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: